Patents/Assignees

KLING BIOTHERAPEUTICS B.V.

3 patents in portfolio

US12084681utility2024
Ex Vivo Antibody Production
0 cites
US11999793utility2024
Therapeutic Anti-cd9 Antibody
0 cites
US11629200utility2023
Means and Methods for Counteracting Myeloproliferative or Lymphoproliferative Disorders
0 cites